# Boston Scientific Corporation (BSX) — Q3-2018 Earnings Results

**Report date:** 2018-10-24 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2018

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Down 0.97%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.35 | N/A | -1.07% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed a cautious optimism regarding future growth despite current market challenges. They emphasized their commitment to innovation and strategic investments.

**Key quotes:**

> Management highlighted ongoing investments in innovation.

> They noted challenges in certain markets but remain focused on long-term growth.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Boston Scientific's earnings report showed a slight miss on EPS, which contributed to a 0.97% decline in stock price. The lack of revenue data and guidance may have raised concerns among investors. Management's cautious tone reflects ongoing challenges but a commitment to future growth through innovation.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2018_